ADAPTIMMUNE THERAPEUTICS PLC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $0.07 per share for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2025-08-13
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-06-30 was $0.07, a 63.16% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-03-31 was $0.07, a 41.67% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2024-09-30 was $0.13, a 8.33% increase year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2024-06-30 was $0.19, a 280.00% increase year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2018 was $0.87, a 148.57% increase from fiscal 2017.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2017 was $0.35, a 52.70% decline from fiscal 2016.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2016 was $0.74.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2015 was $0.64, a 392.31% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.07 10-Q · filed 2025-08-13 | $0.07 10-Q · filed 2025-08-13 | ||
| 2025-03-31 | $0.07 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | $0.12 10-Q · filed 2025-05-13 | |||
| 2024-09-30 | $0.13 10-Q · filed 2024-11-13 | $0.12 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | $0.19 10-Q · filed 2025-08-13 | $0.12 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $0.12 10-Q · filed 2024-05-15 | |||
| 2023-09-30 | $0.12 10-Q · filed 2024-11-13 | $0.12 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $0.05 10-Q · filed 2024-08-12 | $0.08 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $0.25 10-Q · filed 2024-05-15 | |||
| 2022-09-30 | $0.21 10-Q · filed 2023-11-08 | $0.37 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $0.25 10-Q · filed 2023-08-09 | $0.41 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $0.43 10-Q · filed 2023-05-12 | |||
| 2021-09-30 | $0.51 10-Q · filed 2022-11-08 | $0.70 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $0.65 10-Q · filed 2022-08-04 | $0.75 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $0.75 10-Q · filed 2022-05-09 | |||
| 2020-09-30 | $1.25 10-Q · filed 2021-11-04 | $0.57 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $0.30 10-Q · filed 2021-08-09 | $0.47 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $0.51 10-Q · filed 2021-05-06 | |||
| 2019-09-30 | $0.31 10-Q · filed 2020-11-05 | $0.48 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $0.39 10-Q · filed 2020-08-06 | $0.54 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $0.55 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | $0.87 10-K · filed 2019-02-27 | |||
| 2018-09-30 | $1.09 10-Q · filed 2019-11-06 | $0.82 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | $1.18 10-Q · filed 2019-08-01 | $0.80 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $0.75 10-Q · filed 2019-05-06 | |||
| 2017-12-31 | $0.35 10-K · filed 2019-02-27 | |||
| 2017-09-30 | $0.34 10-Q · filed 2018-11-06 | $0.34 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $0.42 10-Q · filed 2018-08-02 | $0.35 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $0.34 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $0.74 10-K · filed 2019-02-27 | |||
| 2016-09-30 | $0.74 10-Q · filed 2017-11-02 | $0.74 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | $0.89 10-Q · filed 2017-08-03 | $0.70 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $0.89 10-Q · filed 2017-05-10 | |||
| 2015-09-30 | $0.94 10-Q · filed 2016-11-10 | |||
| 2015-06-30 | $1.45 10-Q · filed 2016-08-08 | $0.94 10-Q · filed 2016-08-08 | $0.64 10-K · filed 2018-03-15 | |
| 2015-03-31 | $0.83 10-Q · filed 2016-05-12 | |||
| 2014-06-30 | $0.13 10-K · filed 2017-03-13 | |||
| 2013-06-30 | $0.12 8-K · filed 2016-07-08 |